Centric Health Corp. (TSE:CRX – Free Report) – Ventum Cap Mkts decreased their Q4 2024 earnings estimates for shares of Centric Health in a research note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now forecasts that the company will post earnings of ($0.01) per share for the quarter, down from their prior forecast of $0.01. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. Ventum Cap Mkts also issued estimates for Centric Health’s FY2025 earnings at $0.15 EPS.
Separately, Stifel Canada downgraded Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Price Performance
Further Reading
- Five stocks we like better than Centric Health
- What Are Trending Stocks? Trending Stocks Explained
- Rocket Lab is the Right Stock for the Right Time
- Golden Cross Stocks: Pattern, Examples and Charts
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
